Kymera Therapeutics, Inc. Business Operations Contracts & Agreements
5 Contracts & Agreements
- Collaboration Agreements (4 contracts)
- Indemnification Agreements (1)
- Second Amendment to Master Collaboration Agreement between the Registrant and Vertex Pharmaceuticals Incorporated, dated as of October 21, 2021 (Filed With SEC on February 24, 2022)
- First Amendment to Master Collaboration Agreement between the Registrant and Vertex Pharmaceuticals Incorporated, dated as of August 27, 2020 (Filed With SEC on November 5, 2020)
- First Amendment to Collaboration Agreement between the Registrant and GlaxoSmithKline Intellectual Property Development Limited, dated as of August 27, 2020 (Filed With SEC on November 5, 2020)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on August 17, 2020)
- Collaboration Agreement between the Registrant and GlaxoSmithKline Intellectual Property Development Limited, dated as of October 3, 2017 (Filed With SEC on August 5, 2020)
